Continuous Blood Glucose Monitoring Market 2030 Report: Tracking Trends and Growth Status
Global Continuous Blood Glucose Monitoring Market Size Was Valued At USD 5.90 Billion In 2022 And Is Projected To Reach USD 13.28 Billion By 2030, Growing At A CAGR Of 12.3% From 2022 To 2030.
The manufacturing, marketing, and use of medical devices intended to enable real-time glucose level monitoring in people with diabetes are all included in the Continuous Blood Glucose Monitoring (CGM) Market. A tiny sensor that is implanted under the skin measures interstitial glucose levels continually in continuous glucose monitoring (CGM) systems. Data is wirelessly transmitted to a receiver or smartphone for processing and display. With the increased knowledge these devices provide about glucose changes, people can better control their diabetes by changing their food, lifestyle, and insulin dosages in real time. The market places a premium on factors like battery life, wearability, data communication, sensor accuracy, and regulatory compliance. Market dynamics are impacted by things like the rising incidence of diabetes, the need for better diabetes care options, and developments in sensor technology.
Top Key Players Covered in The Continuous Blood Glucose Monitoring Market
Abbott (U.S.), ACON Laboratories (US), ARKRAY (Japan), Ascensia Diabetes Care Holdings AG (Switzerland), B. Braun Melsungen AG (Germany), Beta Bionics, Inc. (US), Dexcom, Inc. (U.S.), Echo Therapeutics Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GlySens Incorporated (US), Integrity Applications Inc., LifeScan IP Holdings, LLC (U.S.), Medisana AG (Germany), Medtronic (Ireland), Metronom Health Inc. (US), Nipro (Japan), Nova Biomedical (US), OrSense Ltd. (Israel), PKvitality (France), Prodigy Diabetes Care (US), Sanofi (France), Senseonics (U.S.), Siren Care, Inc. (US), Terumo Corporation (Japan), Ypsomed (Switzerland), and other major players.
Begin Your Analysis with a Free Sample Report!
Introspective Market Research specializes in delivering comprehensive market research studies that provide valuable insights and strategic guidance to businesses worldwide. Our reports draw data from diverse and solid primary and secondary sources. By utilizing industry-standard tools like Porter's Five Forces Analysis, SWOT Analysis, and Price Trend Analysis, we enhance the comprehensiveness of our evaluations.
In addition to investigating market intricacies, our study focuses extensively on
Global Continuous Blood Glucose Monitoring Market Size Was Valued At USD 5.90 Billion In 2022 And Is Projected To Reach USD 13.28 Billion By 2030, Growing At A CAGR Of 12.3% From 2022 To 2030.
The manufacturing, marketing, and use of medical devices intended to enable real-time glucose level monitoring in people with diabetes are all included in the Continuous Blood Glucose Monitoring (CGM) Market. A tiny sensor that is implanted under the skin measures interstitial glucose levels continually in continuous glucose monitoring (CGM) systems. Data is wirelessly transmitted to a receiver or smartphone for processing and display. With the increased knowledge these devices provide about glucose changes, people can better control their diabetes by changing their food, lifestyle, and insulin dosages in real time. The market places a premium on factors like battery life, wearability, data communication, sensor accuracy, and regulatory compliance. Market dynamics are impacted by things like the rising incidence of diabetes, the need for better diabetes care options, and developments in sensor technology.
Top Key Players Covered in The Continuous Blood Glucose Monitoring Market
Abbott (U.S.), ACON Laboratories (US), ARKRAY (Japan), Ascensia Diabetes Care Holdings AG (Switzerland), B. Braun Melsungen AG (Germany), Beta Bionics, Inc. (US), Dexcom, Inc. (U.S.), Echo Therapeutics Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GlySens Incorporated (US), Integrity Applications Inc., LifeScan IP Holdings, LLC (U.S.), Medisana AG (Germany), Medtronic (Ireland), Metronom Health Inc. (US), Nipro (Japan), Nova Biomedical (US), OrSense Ltd. (Israel), PKvitality (France), Prodigy Diabetes Care (US), Sanofi (France), Senseonics (U.S.), Siren Care, Inc. (US), Terumo Corporation (Japan), Ypsomed (Switzerland), and other major players.
Begin Your Analysis with a Free Sample Report!
Introspective Market Research specializes in delivering comprehensive market research studies that provide valuable insights and strategic guidance to businesses worldwide. Our reports draw data from diverse and solid primary and secondary sources. By utilizing industry-standard tools like Porter's Five Forces Analysis, SWOT Analysis, and Price Trend Analysis, we enhance the comprehensiveness of our evaluations.
In addition to investigating market intricacies, our study focuses extensively on
12:36 PM - Apr 04, 2024 (UTC)
